Takeda, Maverick Therapeutics Enter $125M Cancer Therapy Partnership

From Xconomy VC, Deals, & Startups
January 11, 2017 - 11:23am
Takeda Pharmaceutical, aiming to bolster its cancer drug pipeline, has signed on Maverick Therapeutics to a $125 million partnership for developing new immunotherapy treatments. The funding for Brisbane, CA-based Maverick includes an upfront option, a $23 million Series B investment, and cash for research and development. At the end of the five-year deal, Takeda has […]

Continue reading this article »